Website of the Department of Health

PPRS: provision of additional information relating to sales of branded medicines

Following consultation with the Association of the British Pharmaceutical Industry, it was agreed that members of the Pharmaceutical Price Regulation Scheme (PPRS) would be invited to supply additional information on the sales of branded medicines under the 2005 PPRS, i.e., on a voluntary basis.  Those scheme members that are not prepared to agree to supply the information voluntarily will be subject to Regulations requiring the supply of more detailed information on the sales of their branded medicines.  

Companies will be required to submit information within one calendar month of each quarter.  The first supply of information will be in respect of the quarter ending 31 March 2007. 

All scheme members are invited to sign a letter of consent agreeing to supply the additional information on voluntary basis.  This new letter of consent replaces the letter by which companies consented in November 2004 to comply with the 2005 PPRS.

• Download letter sent to ABPI members (PDF, 34K)
• Download Annex A: additional information required under the 2005 PPRS (PDF, 13K)
• Download Annex B: Excel spreadsheet to provide schedule of information in an electronic format (XLS, 38K)
• Download Annex C: Auditor’s supplementary report covering additional information relating to sales of branded medicines (RTF, 15K)
• Download Annex D PPRS membership form A: certificate of withdrawal of consent for voluntary scheme to be treated as applying (RTF, 10K)
• Download Annex D PPRS membership form B: certificate of consent for voluntary scheme to be treated as applying (RTF, 9K)
• Annex E: The Health Service Medicines (Information Relating to Sales of Branded Medicines etc.) Regulations 2007 (opens new window)